Filip Janku
Inventor
Stats
- 0 US patents issued
- 4 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 4 US Applications Filed
- 5 Total Citation Count
- Jan 26, 2024 Most Recent Filing
- Oct 18, 2014 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| MEMORIAL SLOAN-KETTERING CANCER CENTER | 1
1 | 2014
2015 |
| BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 1
1 | 2014
2015 |
| TROVAGENE, INC. | 1
1 | 2014
2015 |
Inventor Addresses
| Address | Duration |
|---|---|
| Houston, TX, US | May 14, 15 - Jun 27, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| C12Q: | MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0207,301 | 2024 | PHARMACEUTICAL COMPOSITION AND ANTI-TUMOR AGENT FOR TUMOR HAVING DECREASED FUNCTION OF AT LEAST ONE OF BAP1 OR PBRM1 | 0 |
| 11141421 | 2021 | Antitumor agent for biliary tract cancer and method for treating biliary tract cancer | 0 |
| 2020/0352,973 | 2020 | ANTITUMOR AGENT FOR BILIARY TRACT CANCER AND METHOD FOR TREATING BILIARY TRACT CANCER | 1 |
| 2015/0344,957 | 2015 | MONITORING TREATMENT OF HISTIOCYTOSIS WITH VEMURAFENIB AND DABRAFENIB | 1 |
| 2015/0132,256 | 2015 | DETECTING AND MONITORING MUTATIONS IN HISTIOCYTOSIS | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.